China Radiopharmaceuticals in Nuclear Medicine Market Report & Forecast 2021-2027

SKU ID : QYR- 19062862

Publishing Date : 02-Sep-2021

No. of pages : 113

PRICE
3400
5100
6800

  • This report contains market size and forecasts of Radiopharmaceuticals in Nuclear Medicine in China, including the following market information:
    China Radiopharmaceuticals in Nuclear Medicine Market Revenue, 2016-2021, 2022-2027, ($ millions)
    China Radiopharmaceuticals in Nuclear Medicine Market Sales, 2016-2021, 2022-2027, (K MT)
    China top five Radiopharmaceuticals in Nuclear Medicine companies in 2020 (%)
    The global Radiopharmaceuticals in Nuclear Medicine market size is expected to growth from US$ 4804.6 million in 2020 to US$ 6988.2 million by 2027; it is expected to grow at a CAGR of 5.0% during 2021-2027.
    The China Radiopharmaceuticals in Nuclear Medicine market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
    QYResearch has surveyed the Radiopharmaceuticals in Nuclear Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
    Total Market by Segment:
    China Radiopharmaceuticals in Nuclear Medicine Market,

    By Type

    , 2016-2021, 2022-2027 ($ Millions) & (K MT)
    China Radiopharmaceuticals in Nuclear Medicine Market Segment Percentages,

    By Type

    , 2020 (%)
    Diagnostic Radiopharmaceuticals
    Therapy Radiopharmaceuticals
    Enriched Stable Isotopes

    China Radiopharmaceuticals in Nuclear Medicine Market,

    By Application

    , 2016-2021, 2022-2027 ($ Millions) & (K MT)
    China Radiopharmaceuticals in Nuclear Medicine Market Segment Percentages,

    By Application

    , 2020 (%)
    Diagnostic Application
    Therapeutic Application
    Research
    Pharmaceutical
    Other

    Competitor Analysis
    The report also provides analysis of leading market participants including:
    Key companies Radiopharmaceuticals in Nuclear Medicine revenues in China market, 2016-2021 (Estimated), ($ millions)
    Key companies Radiopharmaceuticals in Nuclear Medicine revenues share in China market, 2020 (%)
    Key companies Radiopharmaceuticals in Nuclear Medicine sales in China market, 2016-2021 (Estimated), (K MT)
    Key companies Radiopharmaceuticals in Nuclear Medicine sales share in China market, 2020 (%)
    Further, the report presents profiles of competitors in the market, key players include:
    Bracco Imaging S.P.A.
    Cambridge Isotope Laboratories, Inc.
    Cardinal Health, Inc.
    Covidien, Plc
    Eczacibasi-Monrol
    Fujifilm Holdings Corporation
    GE Healthcare (Subsidiary Of General Electric Company)
    IBA Group
    Isotec, Inc. (Sigma-Aldrich)
    Lantheus Medical Imaging, Inc.
    Nordion, Inc.
    Ntp Radioisotopes (Pty), Ltd.
    Siemens Healthcare (Subsidiary Of Siemens AG)
    Taiyo Nippon Sanso Corporation
    Urenco Limited
    Rotem Industries, Ltd., Inc.
    Australian Nuclear Association And Technology Organization (ANSTO)
    Board of Radiation And Isotope Technology (BRIT)
    Institute of Atomic Energy Polatom Radioisotope Centre
    Institute of Isotopes Co., Ltd.
    Institute Of Radioelement (IRE)


    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports